![](/img/cover-not-exists.png)
MAGELLAN-1, Part 2: Glecaprevir and Pibrentasvir for 12 or 16 Weeks in Patients with Chronic HCV Genotype 1 or 4 and Prior Direct-Acting Antiviral Treatment Failure
Poordad, Fred, Pol, Stanislas, Asatryan, Armen, Buti, Maria, Shaw, David R., Hezode, Christophe, Lalezari, Jacob, Felizarta, Franco, Reindollar, Robert, Gordon, Stuart C., Pianko, Stephen, Fried, MichVolume:
152
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(17)33570-9
Date:
April, 2017
File:
PDF, 890 KB
english, 2017